Gursoy Coruh Aysegul, Uzun Caglar, Akkaya Zehra, Halil Elhan Atilla
Ankara University, School Of Medicine, Radiology, Ankara, Turkey.
Ankara University, School Of Medicine, Biostatistics, Ankara, Turkey.
Turk J Surg. 2020 Sep 28;36(3):241-248. doi: 10.47717/turkjsurg.2020.4877. eCollection 2020 Sep.
The purpose of this study was to investigate the relation between pancreatic steatosis and visceral adiposity. Furthermore, the study sought to explore the association between pancreatic steatosis, pancreas volume, hepatic steatosis, age, and sex in adults without prior history of pancreatic disease. The research also served to define a cut-off value of visceral fat tissue area (VFA) predicting fatty pancreas.
CT scans of 98 living-liver donor transplant patients without prior history of pancreatic disease were evaluated for the presence of fatty pancreas. Pancreas volume, VFA, subcutaneous-total FA, VFA/TFA ratios of the patients with and without fatty pancreas were quantified with a semi-automated model on CT. Coexistence of hepatic steatosis was also recorded.
VFA, TFA and VFA/TFA were significantly greater in the fatty group (p<0.001, p<0.001, p<0.001; respectively), and pancreatic steatosis was moderately correlated with VFA, VFA/TFA and TFA with the highest correlation coefficient with VFA (r=-0.715, r=-0.605, r=-0.573, respectively; p<0.001 for all). A cut-off value of VFA ≥ 107.2 cm2 estimates pancreatic steatosis with a sensitivity and specificity of 90% (95% CI=77-96%) and 87.9% (95% CI=77%-94%), respectively. Pancreas volume was higher in the fatty-group with a mean value of 86.5±17.3 mL (range; 58-119.2 mL, p=0.097). In multiple logistic regression analyses, pancreatic steatosis was significantly associated with VFA and the male sex (OR=58.2, 95% CI=12.2-277.1, p<0.001; OR=11.4, 95% CI=2.1-63.4, p<0.001; respectively). 77.5% of the fatty pancreas subjects had co-existing hepatic steatosis.
Pancreatic steatosis is related to higher VFA, VFA/TFA and hepatic steatosis. A cut-off value of VFA ≥ 107.2 cm may predict pancreatic steatosis.
本研究旨在调查胰腺脂肪变性与内脏肥胖之间的关系。此外,该研究还试图探索无胰腺疾病既往史的成年人中胰腺脂肪变性、胰腺体积、肝脂肪变性、年龄和性别的关联。该研究还用于确定预测胰腺脂肪变性的内脏脂肪组织面积(VFA)的临界值。
对98例无胰腺疾病既往史的活体肝供体移植患者的CT扫描进行评估,以确定是否存在胰腺脂肪变性。使用CT上的半自动模型对有和无胰腺脂肪变性患者的胰腺体积、VFA、皮下总脂肪量、VFA/总脂肪量比值进行量化。还记录了肝脂肪变性的共存情况。
脂肪组的VFA、总脂肪量和VFA/总脂肪量比值显著更高(分别为p<0.001、p<0.001、p<0.001),胰腺脂肪变性与VFA、VFA/总脂肪量和总脂肪量呈中度相关,与VFA的相关系数最高(分别为r=-0.715、r=-0.605、r=-0.573;均p<0.001)。VFA≥107.2 cm²的临界值估计胰腺脂肪变性的敏感性和特异性分别为90%(95%CI=77-96%)和87.9%(95%CI=77%-94%)。脂肪组的胰腺体积更高,平均值为86.5±17.3 mL(范围:58-119.2 mL,p=0.097)。在多因素逻辑回归分析中,胰腺脂肪变性与VFA和男性显著相关(分别为OR=58.2,95%CI=12.2-277.1,p<0.001;OR=11.4,95%CI=2.1-63.4,p<0.001)。77.5%的胰腺脂肪变性患者同时存在肝脂肪变性。
胰腺脂肪变性与更高的VFA、VFA/总脂肪量和肝脂肪变性有关。VFA≥107.2 cm的临界值可能预测胰腺脂肪变性。